Cellid, Co., Ltd. (KOSDAQ:299660)
2,085.00
-35.00 (-1.65%)
Oct 26, 2026, 3:30 PM KST
Cellid, Revenue
In the year 2024, Cellid, had annual revenue of 4.17B KRW. Cellid, had revenue of 1.88B in the quarter ending December 31, 2024. That makes Cellid, the 41,353rd largest company in the world by revenue and 2,537th in South Korea.
Revenue
4.17B
Revenue Growth
n/a
P/S Ratio
n/a
Revenue / Employee
n/a
Employees
n/a
Market Cap
61.51B
Revenue by Segment
- E-commerce 3.81B 91.4%
- New Drug Development 358.05M 8.6%
Fiscal year ended Dec 31, 2024 See the full Cellid, breakdown
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 4.17B | - | - |
| Dec 31, 2023 | - | - | - |
| Dec 31, 2022 | 480.00M | -429.09M | -47.20% |
| Dec 31, 2021 | 909.09M | - | - |
| Dec 31, 2020 | - | - | - |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. It does not take any expenses into account and is therefore different from profits.
Related Stocks
| Company Name | Revenue |
|---|---|
| DongKook Pharmaceutical | 979.60B |
| Huons Global | 846.78B |
| PharmaResearch | 603.58B |
| KOLMAR BNH | 538.18B |
| ST Pharm | 386.46B |
| Sam Chun Dang Pharm. | 259.90B |
| BINEX | 157.28B |
| Oscotec | 144.18B |